---
title: "Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/272128960.md"
description: "Inovio Pharmaceuticals Inc. (INO) shares fell 3.11% to $1.56 on Friday, marking the second consecutive day of losses. This decline occurred despite a strong overall market, with the NASDAQ up 0.81% and the Dow Jones up 0.48%. Inovio's stock is now 47.63% below its 52-week high of $2.98. Compared to competitors, Johnson & Johnson fell 0.66%, Statera Biopharma remained unchanged, and Pfizer rose 0.75%. Trading volume was 1.7 million, surpassing the 50-day average of 1.6 million."
datetime: "2026-01-09T22:25:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272128960.md)
  - [en](https://longbridge.com/en/news/272128960.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272128960.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/272128960.md) | [English](https://longbridge.com/en/news/272128960.md)


# Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Inovio Pharmaceuticals Inc. (INO) slid 3.11% to $1.56 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.81% to 23,671.35 and the Dow Jones Industrial Average rising 0.48% to 49,504.07. This was the stock's second consecutive day of losses. Inovio Pharmaceuticals Inc. closed 47.63% below its 52-week high of $2.98, which the company reached on September 9th. The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.66% to $204.39, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. (PFE) rose 0.75% to $25.48. Trading volume (1.7 M) eclipsed its 50-day average volume of 1.6 M. Data source: Dow Jones Market Data, FactSet. Data compiled January 9, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 01-09-26 1725ET

### 相關股票

- [Inovio Pharma (INO.US)](https://longbridge.com/zh-HK/quote/INO.US.md)

## 相關資訊與研究

- [What's Behind The Drop In Inovio Pharmaceuticals Stock Today?](https://longbridge.com/zh-HK/news/281547274.md)
- [Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program](https://longbridge.com/zh-HK/news/281512814.md)
- [03:47 ETInovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO](https://longbridge.com/zh-HK/news/280975068.md)
- [18:19 ETINO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit](https://longbridge.com/zh-HK/news/281581465.md)
- [INOVIO Announces Pricing of $17.5 Million Public Offering | INO Stock News](https://longbridge.com/zh-HK/news/281527787.md)